Sky Oak Wealth, LLC Bluebird Bio, Inc. Transaction History

Sky Oak Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$11.24 - $21.0 $175,658 - $328,188	-15,628 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$18.04 - $22.09 $6,855 - $8,394	-380 Reduced 2.37%	15,628 $500,000
Q1 2021 Apr 29, 2021	SELL	$16.59 - $33.89 $50,798 - $103,771	-3,062 Reduced 16.06%	16,008 $486,000
Q4 2020 Feb 02, 2021	BUY	$27.5 - $37.92 $524,425 - $723,134	19,070 New	19,070 $825,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky Oak Wealth, LLC with notifications on news.